ICIs Associated With Twofold Increased Psoriasis Risk
TOPLINE:Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk for developing psoriasis compared with those who receive other treatments. METHODOLOGY:Researchers conducted a nationwide cohort…